Colgate-Palmolive Company (CL) Stock Forecast & Price Target
Colgate-Palmolive Company · NYSE
$92.78+0.80 (+0.87%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 19 firms covering Colgate-Palmolive Company, 14 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $86.00 to $110.00, so the covering firms are broadly aligned. The average target of $97.87 sits 5% above the current $92.78. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.92 next quarter toward $4.05 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS19 ratings
Moderate Buy
Strong Buy00%
Buy1474%
Hold526%
Sell00%
Strong Sell00%
Based on 19 analysts giving stock ratings to Colgate-Palmolive Company.
As of Jul, 14 of 19 firms rate CL a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CL EPS & revenue forecast
EPS · NEXT QUARTER
$0.92
Range $0.90 – $0.96 · 17 analysts · +1% YoY
Next period, 17 analysts expect Colgate-Palmolive Company to earn $0.92 a share (range $0.90 – $0.96), versus $0.91 a year earlier. Full-year consensus is $3.81, growing to $4.05 the year after.
REVENUE · NEXT QUARTER
$5.3B
Range $5.3B – $5.4B · 17 analysts · +4% YoY
Revenue is expected to reach $5.3B (range $5.3B – $5.4B), +4.2% year-over-year. Full-year consensus is $21.4B, rising to $22.1B next year.
Top analysts covering Colgate-Palmolive Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CL.
#1
Michael Lavery
Piper Sandler · Rank #94
Buy
$96.00+3.5% to target
Overall win rate
48%
+ Follow
#2
Lauren Lieberman
Barclays · Rank #207
Hold
$87.00-6.2% to target
Overall win rate
43%
+ Follow
#3
Andrea Teixeira
JP Morgan
Buy
$104.00+12.1% to target
Coverage
—
+ Follow
#4
Peter Grom
UBS
Buy
$106.00+14.2% to target
Coverage
—
+ Follow
#5
Chris Carey
Wells Fargo
Hold
$95.00+2.4% to target
Coverage
—
+ Follow
CL stock forecast FAQ
What is CL's average 12-month price target?+
The 15 analysts with a live target average $97.87 for Colgate-Palmolive Company over the next 12 months, ranging from a $110.00 high to a $86.00 low.
Is CL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 19 analyst ratings, 14 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CL?+
The Street-high target is $110.00 (Citigroup), and the Street-low is $86.00 (TD Cowen). The average of all 15 active targets is $97.87.
How many Wall Street analysts cover CL?+
19 analysts have an active rating on Colgate-Palmolive Company, and 15 firms carry a live 12-month price target.
Who is the most accurate analyst covering CL?+
Among analysts who currently cover CL, Michael Lavery of Piper Sandler has the strongest overall Quantellect track record (Rank #94). Their current call is Buy with a $96.00 target.
What is Colgate-Palmolive Company's projected EPS for next quarter?+
The consensus estimate is $0.92 per share (range $0.90 – $0.96) across 17 analysts. Full-year EPS is projected at $3.81, rising to $4.05 the following year.
How much revenue is Colgate-Palmolive Company expected to report next quarter?+
Consensus revenue is $5.3B (range $5.3B – $5.4B). Full-year revenue is projected at $21.4B, growing to $22.1B next year.
Have analysts been upgrading or downgrading CL lately?+
As of Jul, 14 of 19 firms rate CL a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Bernstein
